S&P 500   3,959.22 (-3.17%)
DOW   31,791.28 (-2.64%)
QQQ   294.77 (-3.72%)
AAPL   142.64 (-4.42%)
MSFT   257.07 (-3.65%)
FB   195.28 (-3.62%)
GOOGL   2,258.19 (-3.06%)
AMZN   2,170.00 (-5.95%)
TSLA   723.74 (-4.97%)
NVDA   172.77 (-4.95%)
BABA   88.60 (-3.69%)
NIO   15.95 (-4.09%)
AMD   97.87 (-4.49%)
CGC   5.67 (-3.74%)
MU   71.23 (-4.36%)
T   20.42 (-0.73%)
GE   75.41 (-1.30%)
F   12.90 (-4.66%)
DIS   105.13 (-3.23%)
AMC   13.19 (+2.25%)
PFE   50.32 (-1.99%)
PYPL   78.00 (-2.19%)
NFLX   181.25 (-4.89%)
S&P 500   3,959.22 (-3.17%)
DOW   31,791.28 (-2.64%)
QQQ   294.77 (-3.72%)
AAPL   142.64 (-4.42%)
MSFT   257.07 (-3.65%)
FB   195.28 (-3.62%)
GOOGL   2,258.19 (-3.06%)
AMZN   2,170.00 (-5.95%)
TSLA   723.74 (-4.97%)
NVDA   172.77 (-4.95%)
BABA   88.60 (-3.69%)
NIO   15.95 (-4.09%)
AMD   97.87 (-4.49%)
CGC   5.67 (-3.74%)
MU   71.23 (-4.36%)
T   20.42 (-0.73%)
GE   75.41 (-1.30%)
F   12.90 (-4.66%)
DIS   105.13 (-3.23%)
AMC   13.19 (+2.25%)
PFE   50.32 (-1.99%)
PYPL   78.00 (-2.19%)
NFLX   181.25 (-4.89%)
S&P 500   3,959.22 (-3.17%)
DOW   31,791.28 (-2.64%)
QQQ   294.77 (-3.72%)
AAPL   142.64 (-4.42%)
MSFT   257.07 (-3.65%)
FB   195.28 (-3.62%)
GOOGL   2,258.19 (-3.06%)
AMZN   2,170.00 (-5.95%)
TSLA   723.74 (-4.97%)
NVDA   172.77 (-4.95%)
BABA   88.60 (-3.69%)
NIO   15.95 (-4.09%)
AMD   97.87 (-4.49%)
CGC   5.67 (-3.74%)
MU   71.23 (-4.36%)
T   20.42 (-0.73%)
GE   75.41 (-1.30%)
F   12.90 (-4.66%)
DIS   105.13 (-3.23%)
AMC   13.19 (+2.25%)
PFE   50.32 (-1.99%)
PYPL   78.00 (-2.19%)
NFLX   181.25 (-4.89%)
S&P 500   3,959.22 (-3.17%)
DOW   31,791.28 (-2.64%)
QQQ   294.77 (-3.72%)
AAPL   142.64 (-4.42%)
MSFT   257.07 (-3.65%)
FB   195.28 (-3.62%)
GOOGL   2,258.19 (-3.06%)
AMZN   2,170.00 (-5.95%)
TSLA   723.74 (-4.97%)
NVDA   172.77 (-4.95%)
BABA   88.60 (-3.69%)
NIO   15.95 (-4.09%)
AMD   97.87 (-4.49%)
CGC   5.67 (-3.74%)
MU   71.23 (-4.36%)
T   20.42 (-0.73%)
GE   75.41 (-1.30%)
F   12.90 (-4.66%)
DIS   105.13 (-3.23%)
AMC   13.19 (+2.25%)
PFE   50.32 (-1.99%)
PYPL   78.00 (-2.19%)
NFLX   181.25 (-4.89%)
NASDAQ:ALHC

Alignment Healthcare (ALHC) Stock Forecast, Price & News

$9.42
-0.33 (-3.38%)
(As of 05/18/2022 12:10 PM ET)
Add
Compare
Today's Range
$9.40
$10.00
50-Day Range
$8.03
$11.72
52-Week Range
$6.14
$27.92
Volume
7,973 shs
Average Volume
326,488 shs
Market Capitalization
$1.76 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.53
30 days | 90 days | 365 days | Advanced Chart
Receive ALHC News and Ratings via Email

Sign-up to receive the latest news and ratings for Alignment Healthcare and its competitors with MarketBeat's FREE daily newsletter.

About Alignment Healthcare

Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, and Nevada. It also coordinates and provides covered health care services, including professional, institutional, and ancillary services to members enrolled in certain benefit plans of unaffiliated Medicare Advantage Health Maintenance Organizations. The company was founded in 2013 and is based in Orange, California.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Hospital & medical service plans
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ALHC
Fax
N/A
Employees
847
Year Founded
N/A

Sales & Book Value

Annual Sales
$1.17 billion
Book Value
$1.63 per share

Profitability

Net Income
$-195.29 million
Pretax Margin
-16.72%

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$1.76 billion
Optionable
Not Optionable

Company Calendar

Last Earnings
5/05/2022
Today
5/18/2022
Next Earnings (Estimated)
8/08/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

2.53 out of 5 stars

Medical Sector

117th out of 1,426 stocks

Hospital & Medical Service Plans Industry

5th out of 13 stocks

Analyst Opinion: 4.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -













Alignment Healthcare (NASDAQ:ALHC) Frequently Asked Questions

Is Alignment Healthcare a buy right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alignment Healthcare in the last year. There are currently 9 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Alignment Healthcare stock.
View analyst ratings for Alignment Healthcare
or view top-rated stocks.

When is Alignment Healthcare's next earnings date?

Alignment Healthcare is scheduled to release its next quarterly earnings announcement on Monday, August 8th 2022.
View our earnings forecast for Alignment Healthcare
.

How were Alignment Healthcare's earnings last quarter?

Alignment Healthcare, Inc. (NASDAQ:ALHC) issued its quarterly earnings results on Thursday, May, 5th. The company reported ($0.23) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.24) by $0.01. Alignment Healthcare had a negative trailing twelve-month return on equity of 55.35% and a negative net margin of 14.38%. During the same period in the prior year, the company posted ($0.37) EPS.
View Alignment Healthcare's earnings history
.

What guidance has Alignment Healthcare issued on next quarter's earnings?

Alignment Healthcare updated its second quarter 2022 earnings guidance on Monday, May, 16th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $335.00 million-$340.00 million, compared to the consensus revenue estimate of $339.68 million.

What price target have analysts set for ALHC?

9 brokers have issued 1-year price objectives for Alignment Healthcare's shares. Their forecasts range from $11.00 to $28.00. On average, they anticipate Alignment Healthcare's share price to reach $18.75 in the next year. This suggests a possible upside of 99.0% from the stock's current price.
View analysts' price targets for Alignment Healthcare
or view top-rated stocks among Wall Street analysts.

Who are Alignment Healthcare's key executives?
Alignment Healthcare's management team includes the following people:
Who are some of Alignment Healthcare's key competitors?
When did Alignment Healthcare IPO?

(ALHC) raised $490 million in an IPO on Friday, March 26th 2021. The company issued 27,200,000 shares at $17.00-$19.00 per share. Goldman Sachs, Morgan Stanley, J.P. Morgan, BofA Securities and William Blair served as the underwriters for the IPO and UBS Investment Bank, Piper Sandler and Raymond James were co-managers.

What is Alignment Healthcare's stock symbol?

Alignment Healthcare trades on the NASDAQ under the ticker symbol "ALHC."

Who are Alignment Healthcare's major shareholders?

Alignment Healthcare's stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (3.30%), Durable Capital Partners LP (3.16%), BlackRock Inc. (2.29%), Brown Advisory Inc. (1.90%), State Street Corp (0.68%) and Goldman Sachs Group Inc. (0.59%). Company insiders that own Alignment Healthcare stock include Atlantic (Aln Hlth) L General, Dawn Christine Maroney, Dinesh M Kumar, Donald Steven Furman, Jeffrey H Margolis, John E Kao, Michael Curtis Foster, Richard A Cross, Robert Thomas Freeman and Warburg Pincus Llc.
View institutional ownership trends for Alignment Healthcare
.

Which institutional investors are selling Alignment Healthcare stock?

ALHC stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., TD Asset Management Inc., Goldman Sachs Group Inc., Renaissance Technologies LLC, JPMorgan Chase & Co., State Street Corp, Bank of New York Mellon Corp, and Northern Trust Corp. Company insiders that have sold Alignment Healthcare company stock in the last year include Atlantic (Aln Hlth) L General, Dawn Christine Maroney, Dinesh M Kumar, Donald Steven Furman, Jeffrey H Margolis, John E Kao, Richard A Cross, and Robert Thomas Freeman.
View insider buying and selling activity for Alignment Healthcare
or view top insider-selling stocks.

Which institutional investors are buying Alignment Healthcare stock?

ALHC stock was acquired by a variety of institutional investors in the last quarter, including Durable Capital Partners LP, Brown Advisory Inc., Fortem Financial Group LLC, Invesco Ltd., Eagle Asset Management Inc., PDT Partners LLC, Vanguard Group Inc., and Inspire Investing LLC.
View insider buying and selling activity for Alignment Healthcare
or or view top insider-buying stocks.

How do I buy shares of Alignment Healthcare?

Shares of ALHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Alignment Healthcare's stock price today?

One share of ALHC stock can currently be purchased for approximately $9.42.

How much money does Alignment Healthcare make?

Alignment Healthcare has a market capitalization of $1.76 billion and generates $1.17 billion in revenue each year. The company earns $-195.29 million in net income (profit) each year or ($1.01) on an earnings per share basis.

How many employees does Alignment Healthcare have?

Alignment Healthcare employs 847 workers across the globe.

What is Alignment Healthcare's official website?

The official website for Alignment Healthcare is www.alignmenthealthcare.com.

How can I contact Alignment Healthcare?

Alignment Healthcare's mailing address is 1100 W. TOWN AND COUNTRY ROAD SUITE 1600, ORANGE CA, 92868. The company can be reached via phone at 844-310-2247 or via email at [email protected].

This page was last updated on 5/18/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.